|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1 to 100 out of 545 for Adam17

<< First    < Previous  |  Next >    Last >>
0.759s

Categories

Hits by Pathway

Hits by Strain

Hits by Category

Type Details Score
Gene
6868 | ADAM17
Type: gene
Organism: human
•
•
•
•
•
Gene
475662 | ADAM17
Type: gene
Organism: dog, domestic
•
•
•
•
•
Gene
517541 | ADAM17
Type: gene
Organism: cattle
•
•
•
•
•
Gene
421931 | ADAM17
Type: gene
Organism: chicken
•
•
•
•
•
Gene
694429 | ADAM17
Type: gene
Organism: macaque, rhesus
•
•
•
•
•
Gene
100492947 | adam17
Type: gene
Organism: frog, western clawed
•
•
•
•
•
Gene
57027 | Adam17
Type: gene
Organism: rat
•
•
•
•
•
Gene
459018 | ADAM17
Type: gene
Organism: chimpanzee
•
•
•
•
•
Protein Coding Gene
MGI:1096335 | Adam17
Type: protein_coding_gene
Organism: mouse, laboratory
•
•
•
•
•
Publication
23228566 | J:199061
First Author: Wang Y
Year: 2013
Journal: Biochim Biophys Acta
Title: ADAM17 cleaves CD16b (FcγRIIIb) in human neutrophils.
Volume: 1833
Issue: 3
Pages: 680-5
•
•
•
•
•
Publication
21411748 | J:172873
First Author: Kommaddi RP
Year: 2011
Journal: FASEB J
Title: Trk-dependent ADAM17 activation facilitates neurotrophin survival signaling.
Volume: 25
Issue: 6
Pages: 2061-70
•
•
•
•
•
Publication
21603616 | J:172742
First Author: Arndt PG
Year: 2011
Journal: PLoS One
Title: Leukocyte ADAM17 regulates acute pulmonary inflammation.
Volume: 6
Issue: 5
Pages: e19938
•
•
•
•
•
Publication
36733457 | J:343355
 
First Author: Shoykhet M
Year: 2023
Journal: Front Cell Dev Biol
Title: Cardiomyocyte cohesion is increased after ADAM17 inhibition.
Volume: 11
Pages: 1021595
•
•
•
•
•
Publication
33181031 | J:323985
First Author: Saad MI
Year: 2021
Journal: Am J Respir Cell Mol Biol
Title: ADAM17 Deficiency Protects against Pulmonary Emphysema.
Volume: 64
Issue: 2
Pages: 183-195
•
•
•
•
•
Publication
31257400 | J:290328
First Author: Saad MI
Year: 2020
Journal: Carcinogenesis
Title: The ADAM17 protease promotes tobacco smoke carcinogen-induced lung tumorigenesis.
Volume: 41
Issue: 4
Pages: 527-538
•
•
•
•
•
Publication
22055939 | J:186287
First Author: Sel S
Year: 2012
Journal: Ann Anat
Title: Expression analysis of ADAM17 during mouse eye development.
Volume: 194
Issue: 4
Pages: 334-8
•
•
•
•
•
Publication
27161080 | J:239935
 
First Author: Sommer A
Year: 2016
Journal: Nat Commun
Title: Phosphatidylserine exposure is required for ADAM17 sheddase function.
Volume: 7
Pages: 11523
•
•
•
•
•
Publication
25218057 | J:310397
First Author: Caolo V
Year: 2015
Journal: Angiogenesis
Title: ADAM10 and ADAM17 have opposite roles during sprouting angiogenesis.
Volume: 18
Issue: 1
Pages: 13-22
•
•
•
•
•
Publication
23657465 | J:200543
First Author: Groot AJ
Year: 2013
Journal: J Invest Dermatol
Title: Epidermal ADAM17 is dispensable for notch activation.
Volume: 133
Issue: 9
Pages: 2286-8
•
•
•
•
•
Publication
19201900 | J:144780
First Author: Wang Y
Year: 2009
Journal: J Immunol
Title: Regulation of mature ADAM17 by redox agents for L-selectin shedding.
Volume: 182
Issue: 4
Pages: 2449-57
•
•
•
•
•
Publication
34919140 | J:341780
 
First Author: Bolik J
Year: 2022
Journal: J Exp Med
Title: Inhibition of ADAM17 impairs endothelial cell necroptosis and blocks metastasis.
Volume: 219
Issue: 1
•
•
•
•
•
Publication
18762577 | J:138782
First Author: West MA
Year: 2008
Journal: J Cell Biol
Title: TLR ligand-induced podosome disassembly in dendritic cells is ADAM17 dependent.
Volume: 182
Issue: 5
Pages: 993-1005
•
•
•
•
•
Publication
31564162 | J:280570
First Author: Mukerjee S
Year: 2019
Journal: Hypertension
Title: ACE2 and ADAM17 Interaction Regulates the Activity of Presympathetic Neurons.
Volume: 74
Issue: 5
Pages: 1181-1191
•
•
•
•
•
Publication
29472497 | J:258845
First Author: Schmidt S
Year: 2018
Journal: J Exp Med
Title: ADAM17 is required for EGF-R-induced intestinal tumors via IL-6 trans-signaling.
Volume: 215
Issue: 4
Pages: 1205-1225
•
•
•
•
•
Publication
27642633 | J:302751
 
First Author: Kefaloyianni E
Year: 2016
Journal: JCI Insight
Title: ADAM17 substrate release in proximal tubule drives kidney fibrosis.
Volume: 1
Issue: 13
•
•
•
•
•
Publication
25308957 | J:230318
First Author: Becker AM
Year: 2015
Journal: Exp Hematol
Title: ADAM17 limits the expression of CSF1R on murine hematopoietic progenitors.
Volume: 43
Issue: 1
Pages: 44-52.e1-3
•
•
•
•
•
Publication
23732913 | J:204569
First Author: Hall KC
Year: 2013
Journal: Mol Cell Biol
Title: ADAM17 controls endochondral ossification by regulating terminal differentiation of chondrocytes.
Volume: 33
Issue: 16
Pages: 3077-90
•
•
•
•
•
Publication
28062509 | J:262649
First Author: Nicolaou A
Year: 2017
Journal: Arterioscler Thromb Vasc Biol
Title: Adam17 Deficiency Promotes Atherosclerosis by Enhanced TNFR2 Signaling in Mice.
Volume: 37
Issue: 2
Pages: 247-257
•
•
•
•
•
Publication
23211830 | J:214578
First Author: Hassemer EL
Year: 2013
Journal: Invest Ophthalmol Vis Sci
Title: ADAM17 transactivates EGFR signaling during embryonic eyelid closure.
Volume: 54
Issue: 1
Pages: 132-40
•
•
•
•
•
Publication
36215509 | J:335181
First Author: Saad MI
Year: 2022
Journal: Proc Natl Acad Sci U S A
Title: Blockade of the protease ADAM17 ameliorates experimental pancreatitis.
Volume: 119
Issue: 42
Pages: e2213744119
•
•
•
•
•
GXD Expression
GXD Expression
   
Probe: MGI:6166928
Assay Type: RNA in situ
Annotation Date: 2018-07-25
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1689419
Pattern: Not Specified
Stage: TS19
Assay Id: MGI:6189733
Age: embryonic day 11.5
Specimen Label: Table S2 - E11.5 - Adam17
Detected: true
Specimen Num: 1
•
•
•
•
•
GXD Expression
GXD Expression
   
Probe: MGI:6166928
Assay Type: RNA in situ
Annotation Date: 2018-07-25
Strength: Present
Sex: Male
Emaps: EMAPS:1689424
Pattern: Not Specified
Stage: TS24
Assay Id: MGI:6189733
Age: embryonic day 15.5
Specimen Label: Table S2 - E15.5 - Adam17
Detected: true
Specimen Num: 3
•
•
•
•
•
GXD Expression
GXD Expression
     
Probe: MGI:6166928
Assay Type: RNA in situ
Annotation Date: 2018-07-25
Strength: Absent
Sex: Male
Emaps: EMAPS:1689426
Stage: TS26
Assay Id: MGI:6189733
Age: embryonic day 18.5
Specimen Label: Table S2 - E18.5 - Adam17
Detected: false
Specimen Num: 4
•
•
•
•
•
GXD Expression
GXD Expression
     
Probe: MGI:6166928
Assay Type: RNA in situ
Annotation Date: 2018-07-25
Strength: Absent
Sex: Male
Emaps: EMAPS:1689428
Stage: TS28
Assay Id: MGI:6189733
Age: postnatal day 14
Specimen Label: Table S2 - P14 - Adam17
Detected: false
Specimen Num: 6
•
•
•
•
•
GXD Expression
GXD Expression
     
Probe: MGI:6166928
Assay Type: RNA in situ
Annotation Date: 2018-07-25
Strength: Absent
Sex: Male
Emaps: EMAPS:1689428
Stage: TS28
Assay Id: MGI:6189733
Age: postnatal day 28
Specimen Label: Table S2 - P28 - Adam17
Detected: false
Specimen Num: 7
•
•
•
•
•
GXD Expression
GXD Expression
   
Probe: MGI:6166928
Assay Type: RNA in situ
Annotation Date: 2018-07-25
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1689421
Pattern: Not Specified
Stage: TS21
Assay Id: MGI:6189733
Age: embryonic day 13.5
Specimen Label: Table S2 - E13.5 - Adam17
Detected: true
Specimen Num: 2
•
•
•
•
•
GXD Expression
GXD Expression
     
Probe: MGI:6166928
Assay Type: RNA in situ
Annotation Date: 2018-07-25
Strength: Absent
Sex: Male
Emaps: EMAPS:1689428
Stage: TS28
Assay Id: MGI:6189733
Age: postnatal day 4
Specimen Label: Table S2 - P4 - Adam17
Detected: false
Specimen Num: 5
•
•
•
•
•
Publication
34937930 | J:320534
First Author: Kubo S
Year: 2022
Journal: Nat Immunol
Title: Congenital iRHOM2 deficiency causes ADAM17 dysfunction and environmentally directed immunodysregulatory disease.
Volume: 23
Issue: 1
Pages: 75-85
•
•
•
•
•
Publication
36720499 | J:333038
 
First Author: Badenes M
Year: 2023
Journal: Life Sci Alliance
Title: The ADAM17 sheddase complex regulator iTAP/Frmd8 modulates inflammation and tumor growth.
Volume: 6
Issue: 4
•
•
•
•
•
Publication
25108021 | J:320779
First Author: Marczynska J
Year: 2014
Journal: J Immunol
Title: The role of metalloproteinase ADAM17 in regulating ICOS ligand-mediated humoral immune responses.
Volume: 193
Issue: 6
Pages: 2753-63
•
•
•
•
•
Publication
16735599 | J:139478
First Author: Li Y
Year: 2006
Journal: Blood
Title: ADAM17 deficiency by mature neutrophils has differential effects on L-selectin shedding.
Volume: 108
Issue: 7
Pages: 2275-9
•
•
•
•
•
Publication
16179345 | J:143683
First Author: Aktas B
Year: 2005
Journal: J Biol Chem
Title: Aspirin induces platelet receptor shedding via ADAM17 (TACE).
Volume: 280
Issue: 48
Pages: 39716-22
•
•
•
•
•
Publication
22623356 | J:188073
First Author: Long C
Year: 2012
Journal: J Leukoc Biol
Title: ADAM17 activation in circulating neutrophils following bacterial challenge impairs their recruitment.
Volume: 92
Issue: 3
Pages: 667-72
•
•
•
•
•
Publication
19704010 | J:153991
First Author: Bozkulak EC
Year: 2009
Journal: Mol Cell Biol
Title: Selective use of ADAM10 and ADAM17 in activation of Notch1 signaling.
Volume: 29
Issue: 21
Pages: 5679-95
•
•
•
•
•
Publication
28947615 | J:281470
First Author: Kawai T
Year: 2017
Journal: Hypertension
Title: Vascular ADAM17 (a Disintegrin and Metalloproteinase Domain 17) Is Required for Angiotensin II/β-Aminopropionitrile-Induced Abdominal Aortic Aneurysm.
Volume: 70
Issue: 5
Pages: 959-963
•
•
•
•
•
Publication
20603312 | J:163380
First Author: Chalaris A
Year: 2010
Journal: J Exp Med
Title: Critical role of the disintegrin metalloprotease ADAM17 for intestinal inflammation and regeneration in mice.
Volume: 207
Issue: 8
Pages: 1617-24
•
•
•
•
•
Publication
34610348 | J:317494
First Author: Schumacher N
Year: 2022
Journal: Biochim Biophys Acta Mol Cell Res
Title: ADAM17 orchestrates Interleukin-6, TNFα and EGF-R signaling in inflammation and cancer.
Volume: 1869
Issue: 1
Pages: 119141
•
•
•
•
•
Publication
32130031 | J:293730
First Author: Suzuki S
Year: 2020
Journal: Am J Physiol Lung Cell Mol Physiol
Title: ADAM17 protects against elastase-induced emphysema by suppressing CD62L+ leukocyte infiltration in mice.
Volume: 318
Issue: 6
Pages: L1172-L1182
•
•
•
•
•
Publication
30355783 | J:267735
First Author: Cabron AS
Year: 2018
Journal: J Immunol
Title: Structural and Functional Analyses of the Shedding Protease ADAM17 in HoxB8-Immortalized Macrophages and Dendritic-like Cells.
Volume: 201
Issue: 10
Pages: 3106-3118
•
•
•
•
•
Publication
29966664 | J:268499
First Author: Li Y
Year: 2018
Journal: Exp Cell Res
Title: ADAM17 promotes cell migration and invasion through the integrin β1 pathway in hepatocellular carcinoma.
Volume: 370
Issue: 2
Pages: 373-382
•
•
•
•
•
Publication
20976179 | J:166217
First Author: Canault M
Year: 2010
Journal: PLoS One
Title: The lack of ADAM17 activity during embryonic development causes hemorrhage and impairs vessel formation.
Volume: 5
Issue: 10
Pages: e13433
•
•
•
•
•
Publication
24338472 | J:213038
First Author: Schwarz J
Year: 2014
Journal: J Biol Chem
Title: Polo-like kinase 2, a novel ADAM17 signaling component, regulates tumor necrosis factor α ectodomain shedding.
Volume: 289
Issue: 5
Pages: 3080-93
•
•
•
•
•
Publication
32751103 | J:302363
 
First Author: Gutsaeva DR
Year: 2020
Journal: Int J Mol Sci
Title: Inactivation of Endothelial ADAM17 Reduces Retinal Ischemia-Reperfusion Induced Neuronal and Vascular Damage.
Volume: 21
Issue: 15
•
•
•
•
•
Publication
20110534 | J:170866
First Author: Weskamp G
Year: 2010
Journal: Circ Res
Title: Pathological neovascularization is reduced by inactivation of ADAM17 in endothelial cells but not in pericytes.
Volume: 106
Issue: 5
Pages: 932-40
•
•
•
•
•
Publication
33383559 | J:305820
 
First Author: Zhang X
Year: 2021
Journal: Biochem Biophys Res Commun
Title: ADAM10 and ADAM17 are degraded by lysosomal pathway via asparagine endopeptidase.
Volume: 537
Pages: 15-21
•
•
•
•
•
Publication
20154226 | J:162272
First Author: Long C
Year: 2010
Journal: J Leukoc Biol
Title: In vivo role of leukocyte ADAM17 in the inflammatory and host responses during E. coli-mediated peritonitis.
Volume: 87
Issue: 6
Pages: 1097-101
•
•
•
•
•
Publication
32103528 | J:304951
First Author: Tang B
Year: 2020
Journal: FASEB J
Title: Substrate-selective protein ectodomain shedding by ADAM17 and iRhom2 depends on their juxtamembrane and transmembrane domains.
Volume: 34
Issue: 4
Pages: 4956-4969
•
•
•
•
•
Publication
17510296 | J:122782
First Author: Bell JH
Year: 2007
Journal: J Leukoc Biol
Title: Role of ADAM17 in the ectodomain shedding of TNF-alpha and its receptors by neutrophils and macrophages.
Volume: 82
Issue: 1
Pages: 173-6
•
•
•
•
•
Publication
31771880 | J:293679
First Author: Lownik JC
Year: 2020
Journal: Biochem Biophys Res Commun
Title: B cell ADAM17 controls T cell independent humoral immune responses through regulation of TACI and CD138.
Volume: 522
Issue: 2
Pages: 442-447
•
•
•
•
•
Publication
22284418 | J:181258
First Author: Murthy A
Year: 2012
Journal: Immunity
Title: Notch activation by the metalloproteinase ADAM17 regulates myeloproliferation and atopic barrier immunity by suppressing epithelial cytokine synthesis.
Volume: 36
Issue: 1
Pages: 105-19
•
•
•
•
•
Publication
24336074 | J:316537
 
First Author: Vidal PM
Year: 2013
Journal: Cell Death Dis
Title: ADAM17 is a survival factor for microglial cells in vitro and in vivo after spinal cord injury in mice.
Volume: 4
Pages: e954
•
•
•
•
•
Publication
18356551 | J:149028
First Author: Holdt LM
Year: 2008
Journal: Arterioscler Thromb Vasc Biol
Title: Increased ADAM17 mRNA expression and activity is associated with atherosclerosis resistance in LDL-receptor deficient mice.
Volume: 28
Issue: 6
Pages: 1097-103
•
•
•
•
•
Publication
20220092 | J:160052
First Author: Wang Y
Year: 2010
Journal: J Immunol
Title: ADAM17 activity and other mechanisms of soluble L-selectin production during death receptor-induced leukocyte apoptosis.
Volume: 184
Issue: 8
Pages: 4447-54
•
•
•
•
•
Publication
23678045 | J:200856
First Author: Ford BM
Year: 2013
Journal: Am J Physiol Renal Physiol
Title: ADAM17 mediates Nox4 expression and NADPH oxidase activity in the kidney cortex of OVE26 mice.
Volume: 305
Issue: 3
Pages: F323-32
•
•
•
•
•
Publication
34073747 | J:322062
 
First Author: Palau V
Year: 2021
Journal: Int J Mol Sci
Title: Both Specific Endothelial and Proximal Tubular Adam17 Deletion Protect against Diabetic Nephropathy.
Volume: 22
Issue: 11
•
•
•
•
•
Publication
30833304 | J:286004
 
First Author: Saad MI
Year: 2019
Journal: EMBO Mol Med
Title: ADAM17 selectively activates the IL-6 trans-signaling/ERK MAPK axis in KRAS-addicted lung cancer.
Volume: 11
Issue: 4
•
•
•
•
•
Publication
15691827 | J:143685
First Author: Rabie T
Year: 2005
Journal: J Biol Chem
Title: Evidence for a role of ADAM17 (TACE) in the regulation of platelet glycoprotein V.
Volume: 280
Issue: 15
Pages: 14462-8
•
•
•
•
•
Publication
22384041 | J:185304
First Author: Hall KC
Year: 2012
Journal: PLoS One
Title: Interleukin-1 stimulates ADAM17 through a mechanism independent of its cytoplasmic domain or phosphorylation at threonine 735.
Volume: 7
Issue: 2
Pages: e31600
•
•
•
•
•
Publication
34075077 | J:343888
First Author: Zbodakova O
Year: 2021
Journal: Sci Rep
Title: ADAM10 and ADAM17 regulate EGFR, c-Met and TNF RI signalling in liver regeneration and fibrosis.
Volume: 11
Issue: 1
Pages: 11414
•
•
•
•
•
Publication
20980382 | J:182913
First Author: Le Gall SM
Year: 2010
Journal: J Cell Sci
Title: ADAM17 is regulated by a rapid and reversible mechanism that controls access to its catalytic site.
Volume: 123
Issue: Pt 22
Pages: 3913-22
•
•
•
•
•
Publication
28104813 | J:246731
First Author: Li X
Year: 2017
Journal: J Cell Sci
Title: Structural modeling defines transmembrane residues in ADAM17 that are crucial for Rhbdf2-ADAM17-dependent proteolysis.
Volume: 130
Issue: 5
Pages: 868-878
•
•
•
•
•
Publication
32060096 | J:287404
First Author: Weskamp G
Year: 2020
Journal: J Biol Chem
Title: ADAM17 stabilizes its interacting partner inactive Rhomboid 2 (iRhom2) but not inactive Rhomboid 1 (iRhom1).
Volume: 295
Issue: 13
Pages: 4350-4358
•
•
•
•
•
Publication
22565824 | J:189051
First Author: Franzke CW
Year: 2012
Journal: J Exp Med
Title: Epidermal ADAM17 maintains the skin barrier by regulating EGFR ligand-dependent terminal keratinocyte differentiation.
Volume: 209
Issue: 6
Pages: 1105-19
•
•
•
•
•
Publication
34509473 | J:340540
First Author: Ma X
Year: 2021
Journal: J Biol Chem
Title: ADAM17 mediates ectodomain shedding of the soluble VLDL receptor fragment in the retinal epithelium.
Volume: 297
Issue: 4
Pages: 101185
•
•
•
•
•
Publication
24833351 | J:213737
First Author: Pruessmeyer J
Year: 2014
Journal: Blood
Title: Leukocytes require ADAM10 but not ADAM17 for their migration and inflammatory recruitment into the alveolar space.
Volume: 123
Issue: 26
Pages: 4077-88
•
•
•
•
•
Publication
23584255 | J:213296
First Author: Driscoll WS
Year: 2013
Journal: Circ Res
Title: Macrophage ADAM17 deficiency augments CD36-dependent apoptotic cell uptake and the linked anti-inflammatory phenotype.
Volume: 113
Issue: 1
Pages: 52-61
•
•
•
•
•
Publication
20976004 | J:220943
First Author: Gravano DM
Year: 2010
Journal: PLoS One
Title: ADAM17 deletion in thymic epithelial cells alters aire expression without affecting T cell developmental progression.
Volume: 5
Issue: 10
Pages: e13528
•
•
•
•
•
Publication
14993236 | J:88801
First Author: Sahin U
Year: 2004
Journal: J Cell Biol
Title: Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands.
Volume: 164
Issue: 5
Pages: 769-79
•
•
•
•
•
Publication
27480833 | J:281074
First Author: Takayanagi T
Year: 2016
Journal: Hypertension
Title: Vascular ADAM17 as a Novel Therapeutic Target in Mediating Cardiovascular Hypertrophy and Perivascular Fibrosis Induced by Angiotensin II.
Volume: 68
Issue: 4
Pages: 949-955
•
•
•
•
•
Publication
23755270 | J:203202
First Author: Li Q
Year: 2013
Journal: PLoS One
Title: ADAM17 is critical for multipolar exit and radial migration of neuronal intermediate progenitor cells in mice cerebral cortex.
Volume: 8
Issue: 6
Pages: e65703
•
•
•
•
•
Publication
33957124 | J:306272
   
First Author: Lora J
Year: 2021
Journal: J Biol Chem
Title: Targeted truncation of the ADAM17 cytoplasmic domain in mice results in protein destabilization and a hypomorphic phenotype.
Pages: 100733
•
•
•
•
•
Publication
23637177 | J:325503
First Author: Fleck D
Year: 2013
Journal: J Neurosci
Title: Dual cleavage of neuregulin 1 type III by BACE1 and ADAM17 liberates its EGF-like domain and allows paracrine signaling.
Volume: 33
Issue: 18
Pages: 7856-69
•
•
•
•
•
Publication
17371977 | J:143629
First Author: Li N
Year: 2007
Journal: J Immunol
Title: Non-cell autonomous expression of TNF-alpha-converting enzyme ADAM17 is required for normal lymphocyte development.
Volume: 178
Issue: 7
Pages: 4214-21
•
•
•
•
•
Publication
24812125 | J:211038
First Author: Kawasaki K
Year: 2014
Journal: Proc Natl Acad Sci U S A
Title: Genetic variants of Adam17 differentially regulate TGFβ signaling to modify vascular pathology in mice and humans.
Volume: 111
Issue: 21
Pages: 7723-8
•
•
•
•
•
Publication
29891514 | J:265279
     
First Author: Tang J
Year: 2018
Journal: Mol Cell Biol
Title: Neutrophil and macrophage cell surface CSF-1 shed by ADAM17 drives mouse macrophage proliferation in acute and chronic inflammation.
•
•
•
•
•
Publication
27059842 | J:270124
First Author: Mishra HK
Year: 2016
Journal: J Leukoc Biol
Title: Targeting ADAM17 in leukocytes increases neutrophil recruitment and reduces bacterial spread during polymicrobial sepsis.
Volume: 100
Issue: 5
Pages: 999-1004
•
•
•
•
•
Publication
23354118 | J:195050
First Author: Wilson CL
Year: 2013
Journal: Mech Dev
Title: Endothelial deletion of ADAM17 in mice results in defective remodeling of the semilunar valves and cardiac dysfunction in adults.
Volume: 130
Issue: 4-5
Pages: 272-89
•
•
•
•
•
Publication
37282854 | J:338016
 
First Author: Rabinowitsch AI
Year: 2023
Journal: J Cell Sci
Title: Analysis of the function of ADAM17 in iRhom2 curly-bare and tylosis with esophageal cancer mutant mice.
Volume: 136
Issue: 13
•
•
•
•
•
Publication
24899059 | J:214249
First Author: Beck Gooz M
Year: 2014
Journal: Am J Physiol Renal Physiol
Title: ADAM17 promotes proliferation of collecting duct kidney epithelial cells through ERK activation and increased glycolysis in polycystic kidney disease.
Volume: 307
Issue: 5
Pages: F551-9
•
•
•
•
•
Publication
17344430 | J:120807
First Author: Kawaguchi N
Year: 2007
Journal: J Cell Sci
Title: Different ADAMs have distinct influences on Kit ligand processing: phorbol-ester-stimulated ectodomain shedding of Kitl1 by ADAM17 is reduced by ADAM19.
Volume: 120
Issue: Pt 6
Pages: 943-52
•
•
•
•
•
Publication
26561568 | J:243094
First Author: Yan I
Year: 2016
Journal: J Leukoc Biol
Title: ADAM17 controls IL-6 signaling by cleavage of the murine IL-6Rα from the cell surface of leukocytes during inflammatory responses.
Volume: 99
Issue: 5
Pages: 749-60
•
•
•
•
•
Publication
24227779 | J:207127
First Author: Folgosa L
Year: 2013
Journal: J Immunol
Title: Disturbed follicular architecture in B cell A disintegrin and metalloproteinase (ADAM)10 knockouts is mediated by compensatory increases in ADAM17 and TNF-α shedding.
Volume: 191
Issue: 12
Pages: 5951-8
•
•
•
•
•
Publication
26019295 | J:242737
First Author: DeBerge MP
Year: 2015
Journal: J Leukoc Biol
Title: Shedding of TNF receptor 2 by effector CD8⁺ T cells by ADAM17 is important for regulating TNF-α availability during influenza infection.
Volume: 98
Issue: 3
Pages: 423-34
•
•
•
•
•
Protein
B2RRI4
Organism: Mus musculus/domesticus
Length: 827  
Fragment?: false
•
•
•
•
•
Protein
B2RRI1
Organism: Mus musculus/domesticus
Length: 827  
Fragment?: false
•
•
•
•
•
Publication
22033402 | J:178752
First Author: Lorenzen I
Year: 2011
Journal: Biochem Biophys Res Commun
Title: Multimerisation of A disintegrin and metalloprotease protein-17 (ADAM17) is mediated by its EGF-like domain.
Volume: 415
Issue: 2
Pages: 330-6
•
•
•
•
•
Publication
22575642 | J:184510
First Author: Lorenzen I
Year: 2012
Journal: FEBS Lett
Title: The membrane-proximal domain of A Disintegrin and Metalloprotease 17 (ADAM17) is responsible for recognition of the interleukin-6 receptor and interleukin-1 receptor II.
Volume: 586
Issue: 8
Pages: 1093-100
•
•
•
•
•
Publication
21407195 | J:205661
 
First Author: Maretzky T
Year: 2011
Journal: Nat Commun
Title: Migration of growth factor-stimulated epithelial and endothelial cells depends on EGFR transactivation by ADAM17.
Volume: 2
Pages: 229
•
•
•
•
•
Publication
31455669 | J:284798
 
First Author: Veit M
Year: 2019
Journal: Life Sci Alliance
Title: Mutagenesis of the ADAM17-phosphatidylserine-binding motif leads to embryonic lethality in mice.
Volume: 2
Issue: 5
•
•
•
•
•
Publication
17169360 | J:117695
First Author: Sahin U
Year: 2007
Journal: FEBS Lett
Title: Ectodomain shedding of the EGF-receptor ligand epigen is mediated by ADAM17.
Volume: 581
Issue: 1
Pages: 41-4
•
•
•
•
•




MouseMine is a collaboration between MGI at The Jackson Laboratory and the InterMine project at the Cambridge Systems Biology Centre. MouseMine is funded through a grant from the NIH/NHGRI.The Jackson Laboratory makes no representation about the suitability or accuracy of this software or data for any purpose, and makes no warranties, either express or implied, including merchantability and fitness for a particular purpose or that the use of this software or data will not infringe any third party patents, copyrights, trademarks, or other rights. the software and data are provided "as is". This software and data are provided to enhance knowledge and encourage progress in the scientific community and are to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of the Jackson Laboratory.

Copyright © 2017 by The Jackson Laboratory. All Rights Reserved

© 2002 - 2017 Department of Genetics, University of Cambridge, Downing Street,
Cambridge CB2 3EH, United Kingdom